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ABSTRACT
The causes of lower gastrointestinal bleeding (hematochezia) are amyloidosis, anal fissure, angiodysplastic
lesions, coagulation disorder, colitis, colon cancer, colorectal polyps, Crohn’s disease, diverticulitis,
haemorrhoids, etc.
This was a case of lower gastrointestinal bleeding due to colonic inflammatoric polyp. This inflammatoric
polyps were caused by infection/inflammation  and improved after antibiotic and NSAID therapy.
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INTRODUCTION
Bleeding from the gastrointestinal (GI) tract may
present in five ways: hematemesis, hematochezia,
melena, occult GI bleeding, and only symptoms of blood
loss or anaemia. Hematochezia is the passage of bright
red or maroon blood from the rectum.1 Hematochezia
usually indicates GI bleeding below the ligament of Treitz,
but it may also accompany rapid haemorrhage of 1 L or
more from the upper GI tract.2
Hematochezia ranges from formed, blood-streaked
stools to liquid, bloody stool that may be bright red, dark
mahogany, or maroon in colour. This sign usually
develops abruptly and is heralded by abdominal pain.2
There are many medical causes of hematochezia,
such as: amyloidosis, anal fissure, angiodysplastic lesions,
coagulation disorder, colitis, ulcerative colitis, colon
cancer, colorectal polyps, Crohn’s disease, diverculitis,
dysentery, haemorrhoids, rectal melanoma (malignant),
small-intestine tumours, typhoid fever, etc.1,2,3,4,5,6
CASE ILLUSTRATION
A 19-year old male was admitted to Cipto
Mangunkusumo hospital with a chief complaint bloody
stool one day prior to hospitalisation.
Two months prior to hospitalisation the patient had
diarrhoea with blood and mucous. The blood’s colour
was dark red. There was no history of fever or
abdominal pain. The patient was brought to Ongkomulyo
Hospital, but because there was no improvement of the
symptoms of the disease, the patient was transferred to
Cipto Mangunkusumo Hospital (RSCM). During
hospitalisation in RSCM, the patient underwent
colonoscopy examination, which found infective colitis.
The symptoms then alleviated and the patient was
released from the hospital.
At home there was no complain about defecation,
but since he was suggested to eat soft food, he ate only
soft food. And because he was afraid of having another
bloody stool, he ate very carefully. Sometimes he even
did not eat at all. He also lost his appetite and in the end
his bodyweight dropped about 30 kilograms within two
months.
One-day prior to hospitalisation, the patient had a
bloody stool again. The colour was dark red, with black
clot. There was no history of fever, but the patient had
an abdominal pain in the epigastric and lower abdominal
area. There was history of nausea, but there was no
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vomiting. The patient went to RSCM again and was
hospitalised in the Melati ward. During this time, he
suffered from diarrhoea with blood and mucous for about
eight times per day. The amount of the blood was about
100 cc each. He also had a slight fever, and was getting
weaker.
The patient was a college student, who did not smoke
or drink alcohol. He used to be obese. His weight prior
to his illness was 100 kilograms.
Based on previous history, when the patient was in
the first grade of elementary school, he was hospitalised
because of dengue haemorrhagic fever, and was given
blood transfusion because of low platelet count. The
patient denied any history of diabetes mellitus, liver
disease, or hepatitis.
Based on family history, his father had hypertension
and had a stroke two years previously. The patient
denied history of diabetes mellitus, cancer, colorectal
cancer or any disease of the gastrointestinal system, and
liver disease in the family.
Physical examination demonstrated a weak general
condition but the patient was fully conscious. His blood
pressure was 140/90 mmHg, his pulse rate 90 times per
minute, respiratory rate 20 times per minute, body
temperature 37.9 oC. His conjunctiva were pale, his sclera
demonstrated no jaundice. His jugular venous pressure
was 5-2 cm H2O. The lungs and heart were normal.
Abdominal examination revealed slight epigastric and
lower abdominal pain, the liver and spleen was not
palpable, and the bowel sound was normal. There was
no oedema of the legs, the palmar erythema was not
found. The digital rectal examination revealed dark red
faeces on the hand glove.
Laboratory findings were as follows: haemoglobin
level 14.4 g/dl, haematocrite level 41 vol%, erythrocyte
count 4.9 million/ml, leukocyte count 16.700 per mm3,
and platelet count 529.000 per mm3. Ureum level 27 mg/
dl, creatinin level 0.6 mg/dl, and random blood sugar level
148 mg/dl. The patient’s sodium level was 138 mEq/l,
and his potassium level 4.3 mEq/l. Urinalysis revealed
proteinuria, ketonuria, and bilirubinuria. Chest x-ray
demonstrated a cardio-thoracic index of less than 50%,
and there was no infiltrate. Electrocardiography
demonstrated sinus rhythm, a QRS rate of 100 times per
minute; while NA, ST changes, T inverted and U wave
were not found.
Repeat colonoscopy was performed and resulting in
multiple polyps on the ileal mucous. A sample of the
polyps was then sent to Department of Pathology to be
analyzed and show inflammatory polyps.
The result of ultrasound examination was chronic liver
disease with a differential diagnosis of non-alcoholic
steato-hepatitis, minimal ascites and slight enlargement
of the spleen, and the laboratory results for the serologic
viral hepatitis marker (B and C) were negative. The
patient was then scheduled to have a liver biopsy. The
result of the liver biopsy showed there is nothing
contrary to non-alcoholic steato-hepatitis. So, the liver
problem of this patient was a non-alcoholic steato-hepa-
titis.
DISCUSSION
The patient was a 19 year old male with the history
of recurrent haematochezia. With a history of infective
colitis two months prior to admission, haematochezia was
first thought to have been caused by infective colitis,
even though in infective colitis, such as amebiasis or
shigellosis, the blood usually cannot be seen or there is
usually only a little amount of it, and it rarely causes
severe anaemia requiring blood transfusion.7
The recurrent hematochezia in this patient could have
been caused by several problems, such as infection,
especially with a prior history of infective colitis.
Another causes, such as inflammatory bowel disease,
haemorrhoid, tumour of the colon or small intestine, as
well as diverticulosis were still possible.
Repeated colonoscopy was performed, resulting in
hyperplastic polyps in the ileum, with a differential
diagnosis submucosal tumour, Crohn’s disease, and
hyperplastic lymphoid follicle. The size of the polyps were
smaller compared to those found in the second
colonoscopy.
Since the mucosa was relatively normal, there was a
possibility that the tumour was a submucosal tumour, and
since the biopsy only took the surface of the polyps (the
mucosal part), the condition beneath the mucosal part
was undetected. It required further examination such as
polypectomy, followed by a complete pathological
examination, in order to examine the whole mass.
Treatment should be considered according to the
complete pathological finding.
Crohn’s disease is also known to cause
haematochezia, and this disease could attack the ileum.
Since the aetiology of this disease remain unknown, the
treatment is only based on theories such as reaction to a
persistent intestinal infection, existence of a defective
mucosal barrier to luminal antigens, and a dysregulated
host immune response to ubiquitous antigents.8 The most
common agent that was used for this disease is steroid,
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such as prednisone and methyl prednisolone. Other
agents such like methotrexate and growth hormone had
went through several studies and was said to have some
effects on this disease.9, 10
Surgical therapy should be considered if there is a
complication, or if there is no improvement after
conservative therapy.3, 4 Since the third colonoscopy
showed smaller size of the polyps, the most possible cause
of these polyps was infection. The consideration was
also based on a history of fever and the disappearance
of haematochezia and other symptoms after
administration of antibiotics. This consideration needs to
be supported by further examination such as serial
colonoscopy, where we can evaluate the size and
condition of these polyps after administration of
antibiotics.
Another problem in this patient was the abnormality
in the liver function test, and an abnormal finding in the
ultrasound test. Both chronic hepatitis and non-alcoholic
steato-hepatitis were still possible in this patient, since
there was history of blood transfusion to the patient used
to be obese. Both problems were also two of many
problems that could produced abnormalities in liver
function test results in an asymptomatic person.11 The
negative serologic hepatitis viral marker reduced the
possibility of chronic viral hepatitis in this patient.
Further examination such as liver biopsy was
necessary, since one of the indications for liver biopsy is
for the evaluation of abnormal results of biochemical liver
tests in association with a negative or inconclusive
serologic group12, and the result of the biopsy revealed
that the problem in this patient was non-alcoholic
steato-hepatitis, that may have been related to the
history of obesity in this patient.
Treatment usually involves weight reduction, and a
literature said that the degree of fatty infiltration is
usually reduced with weight loss in most patients,
although the degree of necro-inflammation and fibrosis
may worsen. The rate of weight loss is important and
may have a critical role in determining whether liver
histological findings will improve or worsen.13 Low
cholinesterase and cholesterol levels in this patient may
indicate a worsening process and the beginning of
cirrhosis. It may have been caused by the rapid weight
reduction in this patient.
No medication have been proved to directly reduce
or reverse liver damage independently of weight loss,
but such medication as Gemfibrozil, metformin, Vitamin
E have been shown to improve liver test.13 One study
also said that treatment with various antioxidant improves
the fatty liver that develops in rats.13
This case is presented as a problematic case of a
young patient with recurrent haematochezia, with some
difficulties in making the diagnosis of this patient and
making the decision of the best treatment to this patient
considering the age, cost, and efficacy.
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